News: Lung Cancer

Next Page »

VICC Offers Lung Cancer Screens

Thursday, February 27th, 2014

Vanderbilt-Ingram Cancer Center has launched a new lung cancer screening program to provide low-dose CT scans for patients at high risk for the deadly disease. Current or former smokers ages 55 to 74 who have a history of 30 or more pack years of smoking are eligible for the scans. A pack year is defined […]

Lovly earns Damon Runyon Cancer Research Award

Wednesday, July 17th, 2013

Christine Lovly, M.D., Ph.D., instructor in Medicine at the Vanderbilt University School of Medicine, has earned the 2013 Damon Runyon Clinical Investigator Award, which supports young physician-scientists conducting patient-oriented cancer research. The three-year award will provide $450,000 for Lovly’s research efforts in lung cancer. “I am so honored to receive this prestigious and competitive award […]

Regional variations in benign lung disease

Thursday, May 30th, 2013

By Dagny Stuart A study led by Vanderbilt University Medical Center investigators found that rates of benign lung disease diagnosis varied widely by state following surgery for lung cancer. The results could have an impact on clinical guidelines and health policy for lung cancer screening. The study was presented by Stephen A. Deppen, M.A., M.S., […]

Lung Cancer Research Gets Boost from Breathe Deep Events

Tuesday, November 13th, 2012

More Tennesseans are expected to die this year from lung cancer than any other form of cancer. Yet, lung cancer research receives far less funding than other forms of the disease. To address this funding disparity, the LUNGevity Foundation will host the second annual Breathe Deep 5-K race/walk event, Saturday, Nov. 17, in Nashville’s Centennial […]

Photo: Lung Cancer Partnership

Friday, September 28th, 2012

Caroline Nebhan, right, a fourth-year student in the M.D./Ph.D. training program, explains a cancer research experiment to advocates from the National Lung Cancer Partnership who toured Vanderbilt-Ingram Cancer Center during their recent meeting in Nashville. Nebhan, who works in the research laboratory of William Pao, M.D., Ph.D., is studying the effects of a specific cancer […]

HER2 May Impact Lung Cancer Therapy

Friday, September 21st, 2012

Overcoming therapeutic resistance that inevitably develops is one of the major challenges in treating lung cancer. Non-small cell lung cancers that harbor mutations in the epidermal growth factor receptor (EGFR) are initially responsive to targeted therapies known as EGFR tyrosine kinase inhibitors (TKIs). However, most patients eventually develop resistance to these therapies. One such targeted […]

New Method May Allow Personalized Clinical Trial for Cancer Therapies

Tuesday, August 14th, 2012

A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy – and may offer a way to further refine personalized cancer treatments. The approach, developed by investigators at Vanderbilt-Ingram Cancer Center, shows that erlotinib – a targeted therapy that acts on a growth factor receptor mutated in […]

Study Tracks How Gene May Promote Lung Cancer Tumors

Friday, August 10th, 2012

Vanderbilt-Ingram Cancer Center researchers have identified how one of the genes most commonly mutated in lung cancer may promote such tumors. The investigators found that the protein encoded by this gene, called EPHA3, normally inhibits tumor formation, and that loss or mutation of the gene — as often happens in lung cancer — diminishes this […]

Ancestry Impacts Smoking Risk for Lungs

Wednesday, August 8th, 2012

Smoking tobacco reduces lung function. African Americans have lower lung function compared to European Americans, but it is unclear if African ancestry modifies smoking’s impact on lung function. Melinda Aldrich, Ph.D., MPH, assistant professor of Thoracic Surgery, and colleagues evaluated lung function, tobacco smoking exposure and genetic ancestry in a large population of African Americans who […]

Hassanein Lands Lung Cancer Research Grant

Thursday, August 2nd, 2012

Mohamed Hassanein, Ph.D., research instructor in Pulmonary Medicine, has received a Career Development Award from the LUNGevity Foundation to work on the development of noninvasive tests to help diagnose lung cancer. He will receive $300,000 over three years in support of his research efforts. Hassanein, who specializes in molecular biology and genetics, works in the […]